M4S(R2)
Common Technical Document on Safety
Current edition
Step 4, 20 December 2002
Current edition
Step 4, 20 December 2002
About this standard
Sets the structure and format of the nonclinical summaries in module 2 and the organization of the nonclinical study reports in module 4.
Recognition by market
Whether the market recognizes, harmonizes or adopts this standard, and which edition it accepts
- JapanImplemented
- Edition accepted
- -
- National code
- PFSB/ELD Notification No. 0701004
Effective July 1, 2003
- ChinaImplemented
- Edition accepted
- -
- National code
- CFDA, China Announcement No. 10 (2018)
Effective February 1, 2018
- BrazilImplemented
- Edition accepted
- -
- National code
- -
- GUIA PARA A ORGANIZAÇÃO DO DOCUMENTO TÉCNICO COMUM (CTD) PARA O REGISTRO E PÓS-REGISTRO DE MEDICAMENTOS
Effective August 14, 2019
- South KoreaImplemented
- Edition accepted
- -
- National code
- Guideline on CTD format for Pharmaceuticals[Guideline-0194-02]
Effective June 25, 2015
- SwitzerlandImplemented
- Edition accepted
- -
- National code
- -
Effective December 20, 2002. ICH guidelines apply in Switzerland automatically once they reach Step 4.
- MexicoImplemented
- Edition accepted
- -
- National code
- -
Required: applications for registration of a medicine and for changes to a registration are filed in CTD format under the ICH guidelines, with a Module 1 specific to Mexico.
- SingaporeImplemented
- Edition accepted
- -
- National code
- Guidance on Therapeutic Products Registration in Singapore
Effective January 1, 2003
Testing requirements that cite it
Open the market page and its pathway pages for the full requirement, protocol and report content
Mexico
- Dossier format: CTD under ICH M4 with a Mexican Module 1, language and electronic filingDossier format · Not stated
Saudi Arabia
- Dossier format: eCTD, language and authentication of documentsDossier format · Not stated
Singapore
- Non-clinical documents by application type and evaluation routeNonclinical studies · Not stated
Related standards: FDA eCTD submission guidance, MDR 2017 Fourth Schedule, Appendix II and III, JP notification on electronic study data (2024), M4(R4), M4Q(R1), M4Q(R2), M4E(R2), ACTD, CDSCO Guidance for Industry (Biologicals), COFEPRIS CTD guide v3.0, DS-G-003, DS-REQ-002. See all standards.